Inspira Technologies Secures US Patent for ART500 Tech
Ticker: IINNW · Form: 6-K · Filed: Aug 22, 2025 · CIK: 1837493
Sentiment: bullish
Topics: patent, medical-devices, technology
TL;DR
Inspira just got a US patent for its ART500 tech, aiming to dominate a $20B market. Big news!
AI Summary
On August 22, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced it received U.S. Patent approval for its ART500 core technology. This patent is expected to position the company to lead in an estimated $20 billion market for surgical devices.
Why It Matters
This patent approval is a significant step for Inspira Technologies, potentially solidifying its market position in a large and lucrative sector of the medical device industry.
Risk Assessment
Risk Level: medium — While patent approval is positive, the actual market dominance and revenue generation from the ART500 technology are yet to be proven.
Key Numbers
- $20 billion — Estimated Market Size (The potential market Inspira Technologies aims to lead with its ART500 technology.)
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — The company receiving the patent.
- ART500 (technology) — The core technology for which the patent was granted.
- $20 billion (dollar_amount) — The estimated market size the company aims to dominate.
- August 22, 2025 (date) — The date of the press release and patent approval announcement.
FAQ
What specific medical field does the ART500 technology address?
The filing does not specify the exact medical field, but the context suggests it is related to surgical devices and a $20 billion market.
What is the scope of the U.S. patent granted to Inspira Technologies?
The filing states the patent is for the 'ART500 Core Technology' and is expected to position the company to 'dominate' the market.
When was the press release announcing the patent approval issued?
The press release was issued on August 22, 2025.
What is the company's ticker symbol?
The ticker symbol is not provided in this 6-K filing.
Does this filing indicate any financial performance or guidance from Inspira Technologies?
No, this filing is solely an announcement of a U.S. patent approval and does not contain financial performance data or guidance.
Filing Stats: 331 words · 1 min read · ~1 pages · Grade level 8.5 · Accepted 2025-08-22 08:45:32
Key Financial Figures
- $20 Billion — atent Positions the Company to Dominate $20 Billion Estimated Market,” a copy of whic
Filing Documents
- ea0254314-6k_inspira.htm (6-K) — 11KB
- ea025431401ex99-1_inspira.htm (EX-99.1) — 9KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-079586.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: August 22, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2